glp 1 beta cell GLP-1: Actions on Beta-cell Mass and Function New Insights into Beta-Cell GLP-1

SGLT2 inhibitors when used as an add-on therapy to metformin, insulin, thiazolidinediones, DPP-4 inhibitors, GLP-1 RAs, sulfonylureas, or metformin DPP-4 inhibitor were similarly effective in reducing A1c levels as when used in monotherapy (22,139)

The Institute for Clinical and Economic Review (ICER) found that the lifetime employer cost for Wegovy would be $274,400 , while the medical costs averted over a lifetime would be $61,600

doi: 10.1590/2359-3997000000196 231 TorradoMAraozVBaialardoEAbraldesKMazzaCKrochikGet al

Pregnant or nursing women should avoid use

doi: 10.1016/j.neuropharm.2023.109682

The economic consequences extend beyond healthcare, impacting resources that could otherwise be directed toward development and improving living conditions